CombinatorRx Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • IPO

CombinatorRx General Information

Description

Developer of a novel drug candidate for the treatment of pain and inflammation. The company develops medicine from synergistic combinations and its selective ion-channel modulation platform.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 650 Albany Street
  • Boston, MA 02118
  • United States
+1 (617)
Primary Industry
Drug Discovery
Corporate Office
  • 650 Albany Street
  • Boston, MA 02118
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CombinatorRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. IPO 01-Jan-2005 Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Clinical Trials - Phase 2
To view CombinatorRx’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

CombinatorRx FAQs

  • When was CombinatorRx founded?

    CombinatorRx was founded in 2000.

  • Where is CombinatorRx headquartered?

    CombinatorRx is headquartered in Boston, MA.

  • What industry is CombinatorRx in?

    CombinatorRx’s primary industry is Drug Discovery.

  • Is CombinatorRx a private or public company?

    CombinatorRx is a Private company.

  • What is CombinatorRx’s current revenue?

    The current revenue for CombinatorRx is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »